- Home
- MREO vs AMBC Comparison
MREO vs AMBC Comparison
Compare MREO & AMBC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MREO
- AMBC
- Stock Information
- Founded
- MREO 2015
- AMBC 1971
- Country
- MREO United Kingdom
- AMBC United States
- Employees
- MREO N/A
- AMBC N/A
- Industry
- MREO Biotechnology: Pharmaceutical Preparations
- AMBC Property-Casualty Insurers
- Sector
- MREO Health Care
- AMBC Finance
- Exchange
- MREO Nasdaq
- AMBC Nasdaq
- Market Cap
- MREO 438.8M
- AMBC 411.3M
- IPO Year
- MREO N/A
- AMBC 1991
- Fundamental
- Price
- MREO $1.74
- AMBC $8.05
- Analyst Decision
- MREO Strong Buy
- AMBC Strong Buy
- Analyst Count
- MREO 5
- AMBC 2
- Target Price
- MREO $7.20
- AMBC $12.50
- AVG Volume (30 Days)
- MREO 1.8M
- AMBC 925.2K
- Earning Date
- MREO 08-12-2025
- AMBC 08-07-2025
- Dividend Yield
- MREO N/A
- AMBC N/A
- EPS Growth
- MREO N/A
- AMBC N/A
- EPS
- MREO N/A
- AMBC N/A
- Revenue
- MREO $500,000.00
- AMBC $257,879,000.00
- Revenue This Year
- MREO N/A
- AMBC N/A
- Revenue Next Year
- MREO $38.38
- AMBC $18.20
- P/E Ratio
- MREO N/A
- AMBC N/A
- Revenue Growth
- MREO N/A
- AMBC 148.44
- 52 Week Low
- MREO $1.47
- AMBC $5.99
- 52 Week High
- MREO $5.02
- AMBC $13.64
- Technical
- Relative Strength Index (RSI)
- MREO 44.98
- AMBC 50.38
- Support Level
- MREO $1.64
- AMBC $7.85
- Resistance Level
- MREO $1.78
- AMBC $8.37
- Average True Range (ATR)
- MREO 0.09
- AMBC 0.43
- MACD
- MREO 0.04
- AMBC -0.07
- Stochastic Oscillator
- MREO 87.10
- AMBC 61.66
About MREO Mereo BioPharma Group plc
Mereo BioPharma Group PLC is a United Kingdom (U.K.) based biopharmaceutical company focused on the development of therapeutics for rare diseases. The company has developed a portfolio of late-stage clinical product candidates, and its two rare disease product candidates are setrusumab for the treatment of osteogenesis imperfecta (OI) and alvelestat primarily for the treatment of severe alpha-1 antitrypsin deficiency-associated lung disease (AATD-LD).
About AMBC Ambac Financial Group Inc.
Ambac Financial Group Inc is a financial services holding company. It operates in two principal businesses segments: Insurance Distribution and Specialty Property & Casualty Insurance. Insurance Distribution segment includes Managing General Agents, Underwriters and other appointed and delegated underwriting businesses (collectively MGAs or MGA/Us), an insurance broker, and other distribution and underwriting businesses. Specialty Property & Casualty Insurance includes five carriers (collectively, Everspan). Key revenue is generated from Insurance Distribution.